BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18840136)

  • 1. Sorafenib inhibits MAPK-mediated proliferation in a Barrett's esophageal adenocarcinoma cell line.
    Keswani RN; Chumsangsri A; Mustafi R; Delgado J; Cohen EE; Bissonnette M
    Dis Esophagus; 2008; 21(6):514-21. PubMed ID: 18840136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile salt exposure increases proliferation through p38 and ERK MAPK pathways in a non-neoplastic Barrett's cell line.
    Jaiswal K; Lopez-Guzman C; Souza RF; Spechler SJ; Sarosi GA
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G335-42. PubMed ID: 16239404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sorafenib triggers antiproliferative and pro-apoptotic signals in human esophageal adenocarcinoma cells.
    Delgado JS; Mustafi R; Yee J; Cerda S; Chumsangsri A; Dougherty U; Lichtenstein L; Fichera A; Bissonnette M
    Dig Dis Sci; 2008 Dec; 53(12):3055-64. PubMed ID: 18512153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid increases proliferation via ERK and p38 MAPK-mediated increases in cyclooxygenase-2 in Barrett's adenocarcinoma cells.
    Souza RF; Shewmake K; Pearson S; Sarosi GA; Feagins LA; Ramirez RD; Terada LS; Spechler SJ
    Am J Physiol Gastrointest Liver Physiol; 2004 Oct; 287(4):G743-8. PubMed ID: 15231484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression changes associated with Barrett's esophagus and Barrett's-associated adenocarcinoma cell lines after acid or bile salt exposure.
    Hao Y; Sood S; Triadafilopoulos G; Kim JH; Wang Z; Sahbaie P; Omary MB; Lowe AW
    BMC Gastroenterol; 2007 Jun; 7():24. PubMed ID: 17597535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus.
    Souza RF; Shewmake K; Terada LS; Spechler SJ
    Gastroenterology; 2002 Feb; 122(2):299-307. PubMed ID: 11832445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acid increases MAPK-mediated proliferation in Barrett's esophageal adenocarcinoma cells via intracellular acidification through a Cl-/HCO3- exchanger.
    Sarosi GA; Jaiswal K; Herndon E; Lopez-Guzman C; Spechler SJ; Souza RF
    Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G991-7. PubMed ID: 16081761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
    Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
    J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorafenib induces growth inhibition and apoptosis in human synovial sarcoma cells via inhibiting the RAF/MEK/ERK signaling pathway.
    Peng CL; Guo W; Ji T; Ren T; Yang Y; Li DS; Qu HY; Li X; Tang S; Yan TQ; Tang XD
    Cancer Biol Ther; 2009 Sep; 8(18):1729-36. PubMed ID: 19633425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.
    Ambrosini G; Cheema HS; Seelman S; Teed A; Sambol EB; Singer S; Schwartz GK
    Mol Cancer Ther; 2008 Apr; 7(4):890-6. PubMed ID: 18413802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Barrett's epithelial cells, weakly acidic bile salt solutions cause oxidative DNA damage with response and repair mediated by p38.
    Huo X; Dunbar KB; Zhang X; Zhang Q; Spechler SJ; Souza RF
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G464-G478. PubMed ID: 31984785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dasatinib, a small molecule inhibitor of the Src kinase, reduces the growth and activates apoptosis in pre-neoplastic Barrett's esophagus cell lines: evidence for a noninvasive treatment of high-grade dysplasia.
    Inge LJ; Fowler AJ; Paquette KM; Richer AL; Tran N; Bremner RM
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):531-8. PubMed ID: 23142123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile salt exposure causes phosphatidyl-inositol-3-kinase-mediated proliferation in a Barrett's adenocarcinoma cell line.
    Jaiswal K; Tello V; Lopez-Guzman C; Nwariaku F; Anthony T; Sarosi GA
    Surgery; 2004 Aug; 136(2):160-8. PubMed ID: 15300175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide YY inhibits the growth of Barrett's esophageal adenocarcinoma in vitro.
    McFadden DW; Riggs DR; Jackson BJ; Vona-Davis L
    Am J Surg; 2004 Nov; 188(5):516-9. PubMed ID: 15546561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study.
    Beales IL; Ogunwobi O; Cameron E; El-Amin K; Mutungi G; Wilkinson M
    BMC Cancer; 2007 Jun; 7():97. PubMed ID: 17559672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro.
    Tselepis C; Morris CD; Wakelin D; Hardy R; Perry I; Luong QT; Harper E; Harrison R; Attwood SE; Jankowski JA
    Gut; 2003 Feb; 52(2):174-80. PubMed ID: 12524396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
    Jankowski JA; Anderson M
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of mitogen-activated protein kinases in the esophageal epithelium of patients with Barrett's esophagus.
    Chwiesko A; Baniukiewicz A; Semeniuk J; Kaczmarski M; Wasielica-Berger J; Milewski R; Dabrowski A
    Dis Esophagus; 2015; 28(6):585-92. PubMed ID: 24867362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in activity and phosphorylation of MAPK enzymes in esophageal squamous cells of GERD patients with and without Barrett's esophagus.
    Zhang HY; Zhang X; Chen X; Thomas D; Hormi-Carver K; Elder F; Spechler SJ; Souza RF
    Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G470-8. PubMed ID: 18617556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.